(TRIN) Trinity Capital - Ratings and Ratios
Term Loans, Equipment Financing, Tech Lending, Life Sciences, Private Credit
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 14.80% |
| Yield on Cost 5y | 33.69% |
| Yield CAGR 5y | 12.80% |
| Payout Consistency | 95.5% |
| Payout Ratio | 63.9% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 23.7% |
| Value at Risk 5%th | 37.3% |
| Relative Tail Risk | -4.09% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.14 |
| Alpha | 20.50 |
| CAGR/Max DD | 1.35 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.419 |
| Beta | 0.581 |
| Beta Downside | 0.680 |
| Drawdowns 3y | |
|---|---|
| Max DD | 18.72% |
| Mean DD | 4.36% |
| Median DD | 3.55% |
Description: TRIN Trinity Capital January 20, 2026
Trinity Capital Inc. (NASDAQ: TRIN) is a business-development company (BDC) that originates and invests in term loans, equipment financing, and private-equity-related credit across technology, life-sciences, warehousing, and sponsor-finance segments. Founded in 2019 and headquartered in Phoenix, Arizona (with a satellite office in San Diego), the firm aims to deliver “stable and consistent” returns by tapping the private-credit market, which is largely insulated from public-market volatility.
Key operating metrics (as of the most recent 10-K) show a portfolio of roughly $1.2 billion in assets under management, a weighted-average loan-to-value (LTV) of about 65 %, and an average portfolio yield of 10.3 % annualized. The BDC’s net asset value (NAV) per share has trended upward 12 % year-over-year, reflecting disciplined underwriting and a low default rate (< 2 %).
Sector-level drivers that influence Trinity’s performance include the ongoing “equipment-as-a-service” shift in manufacturing, which fuels demand for flexible leasing structures, and the sustained venture-capital pipeline in life-sciences that creates a pipeline of high-growth, credit-worthy borrowers. Macro-wise, the firm benefits from a steepening credit spread environment when the Fed’s policy rate is high, as investors seek higher-yielding private-credit assets.
For a deeper, data-driven look at TRIN’s valuation and risk profile, you might explore the ValueRay analytics platform’s dedicated TRIN dashboard.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 142.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 31.06 > 1.0 |
| NWC/Revenue: -0.95% < 20% (prev -2.00%; Δ 1.05% < -1%) |
| CFO/TA 0.04 > 3% & CFO 86.5m > Net Income 142.0m |
| Net Debt (-9.47m) to EBITDA (162.9m): -0.06 < 3 |
| Current Ratio: 0.92 > 1.5 & < 3 |
| Outstanding Shares: last quarter (71.5m) vs 12m ago 22.43% < -2% |
| Gross Margin: 78.65% > 18% (prev 0.73%; Δ 7792 % > 0.5%) |
| Asset Turnover: 13.33% > 50% (prev 11.29%; Δ 2.05% > 0%) |
| Interest Coverage Ratio: 0.86 > 6 (EBITDA TTM 162.9m / Interest Expense TTM 75.7m) |
Altman Z'' 0.17
| A: -0.00 (Total Current Assets 28.9m - Total Current Liabilities 31.5m) / Total Assets 2.25b |
| B: -0.01 (Retained Earnings -16.9m / Total Assets 2.25b) |
| C: 0.03 (EBIT TTM 64.9m / Avg Total Assets 1.99b) |
| D: -0.01 (Book Value of Equity -16.8m / Total Liabilities 1.25b) |
| Altman-Z'' Score: 0.17 = B |
Beneish M -2.94
| DSRI: 0.85 (Receivables 19.5m/16.9m, Revenue 265.5m/195.8m) |
| GMI: 0.93 (GM 78.65% / 72.76%) |
| AQI: 1.00 (AQ_t 0.98 / AQ_t-1 0.98) |
| SGI: 1.36 (Revenue 265.5m / 195.8m) |
| TATA: 0.02 (NI 142.0m - CFO 86.5m) / TA 2.25b) |
| Beneish M-Score: -2.94 = A |
ValueRay F-Score (Strict, 0-100) 67.57
| 1. Piotroski: 4.0pt |
| 2. FCF Yield: 4.12% |
| 3. FCF Margin: 32.38% |
| 4. Debt/Equity: 0.88 |
| 5. Debt/Ebitda: -0.06 |
| 6. ROIC - WACC: -2.34% |
| 7. RoE: 15.87% |
| 8. Revenue Trend: 67.19% |
| 9. EPS Trend: 18.94% |
What is the price of TRIN shares?
Over the past week, the price has changed by +2.83%, over one month by +15.46%, over three months by +18.59% and over the past year by +31.19%.
Is TRIN a buy, sell or hold?
- Strong Buy: 6
- Buy: 0
- Hold: 1
- Sell: 0
- Strong Sell: 1
What are the forecasts/targets for the TRIN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 16.6 | -1% |
| Analysts Target Price | 16.6 | -1% |
| ValueRay Target Price | 23.3 | 39.4% |
TRIN Fundamental Data Overview January 22, 2026
P/E Forward = 7.7399
P/S = 4.5421
P/B = 1.221
P/EG = 5.256
Revenue TTM = 265.5m USD
EBIT TTM = 64.9m USD
EBITDA TTM = 162.9m USD
Long Term Debt = unknown (none)
Short Term Debt = 1.31m USD (from shortTermDebt, last fiscal year)
Debt = 877.7m USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -9.47m USD (from netDebt column, last quarter)
Enterprise Value = 2.09b USD (1.22b + Debt 877.7m - CCE 9.47m)
Interest Coverage Ratio = 0.86 (Ebit TTM 64.9m / Interest Expense TTM 75.7m)
EV/FCF = 24.27x (Enterprise Value 2.09b / FCF TTM 86.0m)
FCF Yield = 4.12% (FCF TTM 86.0m / Enterprise Value 2.09b)
FCF Margin = 32.38% (FCF TTM 86.0m / Revenue TTM 265.5m)
Net Margin = 53.49% (Net Income TTM 142.0m / Revenue TTM 265.5m)
Gross Margin = 78.65% ((Revenue TTM 265.5m - Cost of Revenue TTM 56.7m) / Revenue TTM)
Gross Margin QoQ = 68.32% (prev 76.29%)
Tobins Q-Ratio = 0.93 (Enterprise Value 2.09b / Total Assets 2.25b)
Interest Expense / Debt = 2.39% (Interest Expense 21.0m / Debt 877.7m)
Taxrate = 2.28% (644.0k / 28.3m)
NOPAT = 63.4m (EBIT 64.9m * (1 - 2.28%))
Current Ratio = 0.92 (Total Current Assets 28.9m / Total Current Liabilities 31.5m)
Debt / Equity = 0.88 (Debt 877.7m / totalStockholderEquity, last quarter 998.3m)
Debt / EBITDA = -0.06 (Net Debt -9.47m / EBITDA 162.9m)
Debt / FCF = -0.11 (Net Debt -9.47m / FCF TTM 86.0m)
Total Stockholder Equity = 894.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 7.13% (Net Income 142.0m / Total Assets 2.25b)
RoE = 15.87% (Net Income TTM 142.0m / Total Stockholder Equity 894.6m)
RoCE = 2.93% (EBIT 64.9m / Capital Employed (Total Assets 2.25b - Current Liab 31.5m))
RoIC = 3.32% (NOPAT 63.4m / Invested Capital 1.91b)
WACC = 5.66% (E(1.22b)/V(2.10b) * Re(8.05%) + D(877.7m)/V(2.10b) * Rd(2.39%) * (1-Tc(0.02)))
Discount Rate = 8.05% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 21.89%
[DCF Debug] Terminal Value 86.35% ; FCFF base≈86.0m ; Y1≈86.1m ; Y5≈91.3m
Fair Price DCF = 36.10 (EV 2.72b - Net Debt -9.47m = Equity 2.73b / Shares 75.7m; r=5.90% [WACC]; 5y FCF grow -0.45% → 2.90% )
EPS Correlation: 18.94 | EPS CAGR: 8.72% | SUE: -0.04 | # QB: 0
Revenue Correlation: 67.19 | Revenue CAGR: -0.76% | SUE: -1.11 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.52 | Chg30d=-0.001 | Revisions Net=+1 | Analysts=10
EPS next Year (2026-12-31): EPS=2.09 | Chg30d=+0.003 | Revisions Net=+1 | Growth EPS=+0.3% | Growth Revenue=+17.4%
Additional Sources for TRIN Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle